First, does modulation of JNK have more potential benefit for acute events (heart attack, decompensated heart failure), or for chronic conditions such as obesity, insulin resistance, and chronic inflammation? This evidence concerns the gene MAPK8 and obesity due to melanocortin 4 receptor deficiency.